Overall, these results indicate that, suppression of STAT3 induced apoptosis at high levels with 17.2-fold in the parental and 22.25-fold in nilotinib-resistant CML cells (Figures 4E, 4F). The gene discussed is STAT3; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.